Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fluoxetine Is a Potent Inhibitor of Coxsackievirus Replication
Jun Zuo, Kevin K. Quinn, Steve Kye, et al.
Antimicrobial Agents and Chemotherapy (2012) Vol. 56, Iss. 9, pp. 4838-4844
Open Access | Times Cited: 92

Showing 1-25 of 92 citing articles:

The life cycle of non-polio enteroviruses and how to target it
Jim Baggen, Hendrik Jan Thibaut, Jeroen R. P. M. Strating, et al.
Nature Reviews Microbiology (2018) Vol. 16, Iss. 6, pp. 368-381
Closed Access | Times Cited: 372
Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19
Vikas P. Sukhatme, Angela M. Reiersen, Sharat J. Vayttaden, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 173
Mortality Risk Among Patients With COVID-19 Prescribed Selective Serotonin Reuptake Inhibitor Antidepressants
Tomiko Oskotsky, Ivana Marić, Alice Tang, et al.
JAMA Network Open (2021) Vol. 4, Iss. 11, pp. e2133090-e2133090
Open Access | Times Cited: 127
Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus
Magloire Pandoua Nekoua, Enagnon Kazali Alidjinou, Didier Hober
Nature Reviews Endocrinology (2022) Vol. 18, Iss. 8, pp. 503-516
Open Access | Times Cited: 99
Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes as an In Vitro Model for Coxsackievirus B3–Induced Myocarditis and Antiviral Drug Screening Platform
Arun Sharma, Caleb Marceau, Ryoko Hamaguchi, et al.
Circulation Research (2014) Vol. 115, Iss. 6, pp. 556-566
Open Access | Times Cited: 144
Enteroviruses in the early 21st century
Debra J. Lugo, Paul Krogstad
Current Opinion in Pediatrics (2015) Vol. 28, Iss. 1, pp. 107-113
Open Access | Times Cited: 130
Recent progress in understanding coxsackievirus replication, dissemination, and pathogenesis
Jon Sin, Vrushali Mangale, Wdee Thienphrapa, et al.
Virology (2015) Vol. 484, pp. 288-304
Open Access | Times Cited: 95
Direct-acting antivirals and host-targeting strategies to combat enterovirus infections
Lisa Bauer, Heyrhyoung Lyoo, Hilde M. van der Schaar, et al.
Current Opinion in Virology (2017) Vol. 24, pp. 1-8
Open Access | Times Cited: 93
Widely available lysosome targeting agents should be considered as potential therapy for COVID-19
Jan Homolak, Ivan Kodvanj
International Journal of Antimicrobial Agents (2020) Vol. 56, Iss. 2, pp. 106044-106044
Open Access | Times Cited: 70
Selective Serotonin Reuptake Inhibitor Fluoxetine Inhibits Replication of Human Enteroviruses B and D by Targeting Viral Protein 2C
Rachel Ulferts, Lonneke van der Linden, Hendrik Jan Thibaut, et al.
Antimicrobial Agents and Chemotherapy (2013) Vol. 57, Iss. 4, pp. 1952-1956
Open Access | Times Cited: 89
Enteroviruses in X-Linked Agammaglobulinemia: Update on Epidemiology and Therapy∗
David Bearden, Marc S. Collett, P. Lan Quan, et al.
The Journal of Allergy and Clinical Immunology In Practice (2016) Vol. 4, Iss. 6, pp. 1059-1065
Closed Access | Times Cited: 80
Identification of Luteolin as Enterovirus 71 and Coxsackievirus A16 Inhibitors through Reporter Viruses and Cell Viability-Based Screening
Lin Xu, Weiheng Su, Jun Jin, et al.
Viruses (2014) Vol. 6, Iss. 7, pp. 2778-2795
Open Access | Times Cited: 77
Screening of a Library of FDA-Approved Drugs Identifies Several Enterovirus Replication Inhibitors That Target Viral Protein 2C
Rachel Ulferts, S.M. de Boer, Lonneke van der Linden, et al.
Antimicrobial Agents and Chemotherapy (2016) Vol. 60, Iss. 5, pp. 2627-2638
Open Access | Times Cited: 72
Acute Flaccid Paralysis and Enteroviral Infections
Ari Bitnun, E. Ann Yeh
Current Infectious Disease Reports (2018) Vol. 20, Iss. 9
Closed Access | Times Cited: 65
Fluoxetine Inhibits Enterovirus Replication by Targeting the Viral 2C Protein in a Stereospecific Manner
Lisa Bauer, Roberto Manganaro, Birgit Zonsics, et al.
ACS Infectious Diseases (2019) Vol. 5, Iss. 9, pp. 1609-1623
Open Access | Times Cited: 62
Project IDentif.AI: Harnessing Artificial Intelligence to Rapidly Optimize Combination Therapy Development for Infectious Disease Intervention
Aynur Abdulla, Boqian Wang, Qian Feng, et al.
Advanced Therapeutics (2020) Vol. 3, Iss. 7
Open Access | Times Cited: 59
Enterovirus D68 Antivirals: Past, Present, and Future
Yanmei Hu, Rami Musharrafieh, Madeleine Zheng, et al.
ACS Infectious Diseases (2020) Vol. 6, Iss. 7, pp. 1572-1586
Open Access | Times Cited: 55
Drug repurposing of selective serotonin reuptake inhibitors: Could these drugs help fight COVID-19 and save lives?
Yaser Pashaei
Journal of Clinical Neuroscience (2021) Vol. 88, pp. 163-172
Open Access | Times Cited: 43
Analysis of the impact of antidepressants and other medications on COVID-19 infection risk in a chronic psychiatric in-patient cohort
Catherine L. Clelland, Krista Ramiah, Louisa J. Steinberg, et al.
BJPsych Open (2021) Vol. 8, Iss. 1
Open Access | Times Cited: 42
Rationale for the Evaluation of Fluoxetine in the Treatment of Enterovirus D68-Associated Acute Flaccid Myelitis
Kenneth L. Tyler
JAMA Neurology (2015) Vol. 72, Iss. 5, pp. 493-493
Open Access | Times Cited: 57
Enterovirus Persistence in Cardiac Cells of Patients With Idiopathic Dilated Cardiomyopathy Is Linked to 5’ Terminal Genomic RNA-Deleted Viral Populations With Viral-Encoded Proteinase Activities
Alexis Bouin, Paul-Antoine Gretteau, Michel Wehbe, et al.
Circulation (2019) Vol. 139, Iss. 20, pp. 2326-2338
Open Access | Times Cited: 52
Synthesis and Structure–Activity Relationship (SAR) Studies of Novel Pyrazolopyridine Derivatives as Inhibitors of Enterovirus Replication
Yanpeng Xing, Jun Zuo, Paul Krogstad, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 4, pp. 1688-1703
Closed Access | Times Cited: 48
Treatment of Chronic Enterovirus Encephalitis With Fluoxetine in a Patient With X-Linked Agammaglobulinemia
Jacqueline S. Gofshteyn, Ana María Cárdenas, David Bearden
Pediatric Neurology (2016) Vol. 64, pp. 94-98
Closed Access | Times Cited: 47
Fluoxetine Can Inhibit SARS-CoV-2 In Vitro
Arthur Dechaumes, Magloire Pandoua Nekoua, Sandrine Belouzard, et al.
Microorganisms (2021) Vol. 9, Iss. 2, pp. 339-339
Open Access | Times Cited: 40
Drugs that offer the potential to reduce hospitalization and mortality from SARS-CoV-2 infection: The possible role of the sigma-1 receptor and autophagy
James Michael Brimson, Mani Iyer Prasanth, Dicson Sheeja Malar, et al.
Expert Opinion on Therapeutic Targets (2021) Vol. 25, Iss. 6, pp. 435-449
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top